NCT01835093View on ClinicalTrials.gov

An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD)

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

February 28, 2014

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG

Tipepidine Hibenzate

Trial Locations (1)

260-8670

Department of Psychiatry, Chiba University School of Medicine, Chiba

All Listed Sponsors
lead

Chiba University

OTHER

NCT01835093 - An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD) | Biotech Hunter | Biotech Hunter